ASSERTIO

Assertio is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. The company was founded in 1995 and has established itself by developing and incorporating promising technology into differentiated therapeutic products, taking those products through clinical approval, and building a strong market presence. The company currently markets four FDA-approved products, Gralise (gabapentin) tablets for the manage... ment of Postherpetic Neuralgia (PHN), Cambia (diclofenac potassium for oral solution) for the acute treatment of migraine attacks with or without aura in adults 18 years of age or older, Zipsor (diclofenac potassium) liquid-filled capsules for relief of mild to moderate acute pain, and Lazanda (fentanyl) nasal spray CII for the management of breakthrough pain in cancer patients. See Important Safety Information for Gralise, Cambia, Zipsor, and Lazanda.

#SimilarOrganizations #People #Financial #Website #More

ASSERTIO

Social Links:

Industry:

Biotechnology Health Care Health Diagnostics Life Science Medical Pharmaceutical

Founded:

1995-01-01

Address:

Lake Forest, Illinois, United States

Country:

United States

Website Url:

http://www.assertiotx.com

Total Employee:

101+

Status:

Active

Contact:

224.419.7106

Email Addresses:

[email protected]

Total Funding:

1.01 B USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network